Goldman Sachs’s CAREFUSION CORPORATION CFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-7,200
Closed -$427K 7518
2014
Q4
$427K Sell
7,200
-3,000
-29% -$172K ﹤0.01% 5446
2014
Q3
$462K Buy
10,200
+2,000
+24% +$90.1K ﹤0.01% 5352
2014
Q2
$364K Sell
8,200
-191,800
-96% -$7.94M ﹤0.01% 5611
2014
Q1
$8.04M Buy
200,000
+185,900
+1,318% +$7.52M ﹤0.01% 2553
2013
Q4
$561K Sell
14,100
-15,000
-52% -$583K ﹤0.01% 5217
2013
Q3
$1.07M Sell
29,100
-192,800
-87% -$7.2M ﹤0.01% 4537
2013
Q2
$8.18M Buy
+221,900
New +$7.84M ﹤0.01% 2269

Other funds holding CFN

Goldman Sachs's CFN Position: Q1 2015 in Review

Goldman Sachs sold out of CAREFUSION CORPORATION (CFN) in Q1 2015, closing a stake of 1,112,183 shares — an estimated $66M sold.

Goldman Sachs first reported a position in CFN in Q2 2013 and held it in 7 quarters. The position peaked at $311M in Q4 2013. 3 funds tracked by Wall St. Rank hold CFN as of Q1 2015.

  • Goldman Sachs reported no remaining CAREFUSION CORPORATION position as of Q1 2015 after selling out during the quarter.
  • Goldman Sachs sold 1,112,183 CAREFUSION CORPORATION shares in Q1 2015, an estimated $66M.
  • Goldman Sachs first reported a position in CAREFUSION CORPORATION in Q2 2013 and held it in 7 quarters.
  • Goldman Sachs's CAREFUSION CORPORATION position peaked at $311M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.